- Home
- ESEA vs AQST Comparison
ESEA vs AQST Comparison
Compare ESEA & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESEA
- AQST
- Stock Information
- Founded
- ESEA 2005
- AQST 2004
- Country
- ESEA Greece
- AQST United States
- Employees
- ESEA N/A
- AQST N/A
- Industry
- ESEA Marine Transportation
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- ESEA Consumer Discretionary
- AQST Health Care
- Exchange
- ESEA Nasdaq
- AQST Nasdaq
- Market Cap
- ESEA 293.8M
- AQST 473.5M
- IPO Year
- ESEA 2006
- AQST 2018
- Fundamental
- Price
- ESEA $42.40
- AQST $4.92
- Analyst Decision
- ESEA Buy
- AQST Strong Buy
- Analyst Count
- ESEA 1
- AQST 7
- Target Price
- ESEA $53.00
- AQST $9.29
- AVG Volume (30 Days)
- ESEA 57.9K
- AQST 1.2M
- Earning Date
- ESEA 11-07-2024
- AQST 11-04-2024
- Dividend Yield
- ESEA 5.66%
- AQST N/A
- EPS Growth
- ESEA 16.05
- AQST N/A
- EPS
- ESEA 16.98
- AQST N/A
- Revenue
- ESEA $205,168,137.00
- AQST $58,360,000.00
- Revenue This Year
- ESEA $12.83
- AQST $16.97
- Revenue Next Year
- ESEA N/A
- AQST N/A
- P/E Ratio
- ESEA $2.54
- AQST N/A
- Revenue Growth
- ESEA 14.96
- AQST 25.45
- 52 Week Low
- ESEA $22.50
- AQST $1.36
- 52 Week High
- ESEA $50.92
- AQST $6.23
- Technical
- Relative Strength Index (RSI)
- ESEA 42.06
- AQST 54.44
- Support Level
- ESEA $42.00
- AQST $4.74
- Resistance Level
- ESEA $45.26
- AQST $5.04
- Average True Range (ATR)
- ESEA 1.78
- AQST 0.24
- MACD
- ESEA -0.61
- AQST -0.02
- Stochastic Oscillator
- ESEA 9.65
- AQST 55.79
About ESEA Euroseas Ltd. (Marshall Islands)
Euroseas Ltd is a shipping company. Its fleet consists of containerships that transport container boxes providing scheduled service between ports. Its operations are managed by an affiliated ship management company, which is responsible for the day-to-day commercial and technical management and operations of the vessels. The company employs its vessels on spot and period charters and through pool arrangements.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.